Perrigo's Papa joins Valeant as chairman, CEO

LAVAL, Quebec — Valeant Pharmaceuticals announced Monday that Joseph Papa — most recently CEO and chairman of Perrigo — would be the company’s new chairman and CEO. Papa will replace J. Michael Pearson, who will continue as CEO and board director until Papa joins the Valeant in May. 

 

“I am excited to take on the challenge of leading Valeant and helping the company chart a new course," Papa said.  “We have an opportunity to move forward with a renewed focus on operating with integrity across all areas of the business and providing customers with safe and affordable products that improve their lives.”

 

Papa had been at the head of Perrigo since he joined Perrigo in 2006, getting appointed chairman in 2007. Prior to Perrigo, he worked with Cardinal Health and Watson Pharmaceuticals as well as Novartis and Pharmacia/Searle. 

 

Perrigo made its own announcement Monday about its new CEO.